Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 341

1.

Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies.

Chiva-Blanch G, Badimon L.

Nutrients. 2019 Dec 30;12(1). pii: E108. doi: 10.3390/nu12010108. Review.

2.

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.

Representatives of the Global Familial Hypercholesterolemia Community, Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, Almahmeed W, Alonso R, Al-Rasadi K, Badimon L, Bernal LM, Bogsrud MP, Braun LT, Brunham L, Catapano AL, Cillíková K, Corral P, Cuevas R, Defesche JC, Descamps OS, de Ferranti S, Eiselé JL, Elikir G, Folco E, Freiberger T, Fuggetta F, Gaspar IM, Gesztes ÁG, Grošelj U, Hamilton-Craig I, Hanauer-Mader G, Harada-Shiba M, Hastings G, Hovingh GK, Izar MC, Jamison A, Karlsson GN, Kayikçioglu M, Koob S, Koseki M, Lane S, Lima-Martinez MM, López G, Martinez TL, Marais D, Marion L, Mata P, Maurina I, Maxwell D, Mehta R, Mensah GA, Miserez AR, Neely D, Nicholls SJ, Nohara A, Nordestgaard BG, Ose L, Pallidis A, Pang J, Payne J, Peterson AL, Popescu MP, Puri R, Ray KK, Reda A, Sampietro T, Santos RD, Schalkers I, Schreier L, Shapiro MD, Sijbrands E, Soffer D, Stefanutti C, Stoll M, Sy RG, Tamayo ML, Tilney MK, Tokgözoglu L, Tomlinson B, Vallejo-Vaz AJ, Vazquez-Cárdenas A, de Luca PV, Wald DS, Watts GF, Wenger NK, Wolf M, Wood D, Zegerius A, Gaziano TA, Gidding SS.

JAMA Cardiol. 2020 Jan 2. doi: 10.1001/jamacardio.2019.5173. [Epub ahead of print]

PMID:
31895433
3.

CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions.

Rossello X, Rodriguez-Sinovas A, Vilahur G, Crisóstomo V, Jorge I, Zaragoza C, Zamorano JL, Bermejo J, Ordoñez A, Boscá L, Vázquez J, Badimón L, Sánchez-Margallo FM, Fernández-Avilés F, Garcia-Dorado D, Ibanez B.

Sci Rep. 2019 Dec 30;9(1):20290. doi: 10.1038/s41598-019-56613-6.

4.

Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

Task Force Members; ESC National Cardiac Societies; ESC Committee for Practice Guidelines (CPG).

Atherosclerosis. 2019 Dec 20. pii: S0021-9150(19)31611-9. doi: 10.1016/j.atherosclerosis.2019.12.004. [Epub ahead of print] No abstract available.

PMID:
31870624
5.

Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.

Bertomeu-Gonzalez V, Moreno-Arribas J, Esteve-Pastor MA, Roldán-Rabadán I, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA Study Investigators.

J Am Heart Assoc. 2020 Jan 7;9(1):e013789. doi: 10.1161/JAHA.119.013789. Epub 2019 Dec 24.

6.

Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research.

Sánchez-Guijo F, García-Olmo D, Prósper F, Martínez S, Zapata A, Fernández-Avilés F, Toledo-Aral JJ, Torres M, Fariñas I, Badimón L, Labandeira-García JL, García-Sancho J, Moraleda JM; TerCel.

Cytotherapy. 2019 Dec 19. pii: S1465-3249(19)30889-8. doi: 10.1016/j.jcyt.2019.11.001. [Epub ahead of print] Review.

7.

Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

Authors/Task Force Members; ESC National Cardiac Societies; ESC Committee for Practice Guidelines (CPG).

Atherosclerosis. 2020 Jan;292:160-162. doi: 10.1016/j.atherosclerosis.2019.11.020. Epub 2019 Dec 4. No abstract available.

PMID:
31811963
8.

Stem cells from human cardiac adipose tissue depots show different gene expression and functional capacities.

Lambert C, Arderiu G, Bejar MT, Crespo J, Baldellou M, Juan-Babot O, Badimon L.

Stem Cell Res Ther. 2019 Nov 29;10(1):361. doi: 10.1186/s13287-019-1460-1.

9.

Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia.

Mendieta G, Ben-Aicha S, Casani L, Badimon L, Sabate M, Vilahur G.

Basic Res Cardiol. 2019 Nov 28;115(1):2. doi: 10.1007/s00395-019-0760-z.

PMID:
31781960
10.

Cross-Talk between Lipoproteins and Inflammation: The Role of Microvesicles.

Chiva-Blanch G, Badimon L.

J Clin Med. 2019 Nov 22;8(12). pii: E2059. doi: 10.3390/jcm8122059. Review.

11.

Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Andreadou I, Schulz R, Badimon L, Adameová A, Kleinbongard P, Lecour S, Nikolaou PE, Falcão-Pires I, Vilahur G, Woudberg N, Heusch G, Ferdinandy P.

Br J Pharmacol. 2019 Nov 26. doi: 10.1111/bph.14931. [Epub ahead of print] Review.

PMID:
31769007
12.

Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial.

Damask A, Steg PG, Schwartz GG, Szarek M, Hagström E, Badimon L, Chapman MJ, Boileau C, Tsimikas S, Ginsberg HN, Banerjee P, Manvelian G, Pordy R, Hess S, Overton JD, Lotta LA, Yancopoulos GD, Abecasis GR, Baras A, Paulding C; Regeneron Genetics Center and the ODYSSEY OUTCOMES Investigators.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044434. [Epub ahead of print]

PMID:
31707832
13.

Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction.

Cenko E, van der Schaar M, Yoon J, Manfrini O, Vasiljevic Z, Vavlukis M, Kedev S, Miličić D, Badimon L, Bugiardini R.

J Am Coll Cardiol. 2019 Nov 12;74(19):2379-2389. doi: 10.1016/j.jacc.2019.08.1047.

PMID:
31699278
14.

Liquid Biopsies: Microvesicles in Cardiovascular Disease.

Badimon L, Suades R, Vilella-Figuerola A, Crespo J, Vilahur G, Escate R, Padro T, Chiva-Blanch G.

Antioxid Redox Signal. 2019 Dec 17. doi: 10.1089/ars.2019.7922. [Epub ahead of print]

PMID:
31696726
15.

European Society of Cardiology Advocacy.

Badimon L, Zanon E.

Eur Heart J. 2019 Nov 1;40(41):3376-3377. doi: 10.1093/eurheartj/ehz720. No abstract available.

PMID:
31674653
16.

Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease.

Pedro-Botet J, López-Miranda J, Badimón L, Civeira F, Guijarro C, Millán J, Mostaza JM, Pintó X, Valdivielso P, Masana L; Expert group from the Spanish Arteriosclerosis Society.

Am J Cardiovasc Drugs. 2019 Oct 25. doi: 10.1007/s40256-019-00376-y. [Epub ahead of print] Review.

PMID:
31650523
17.

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies.

Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31. No abstract available. Erratum in: Atherosclerosis. 2020 Jan;292:160-162. Atherosclerosis. 2019 Dec 20;:.

18.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group .

Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. No abstract available.

PMID:
31504418
19.

HDL remodelled in hypercholesterolemic blood induce epigenetically driven downregulation of endothelial HIF-1α expression in a preclinical animal model.

Ben-Aicha S, Escate R, Casaní L, Padró T, Peña E, Arderiu G, Mendieta G, Badimón L, Vilahur G.

Cardiovasc Res. 2019 Aug 30. pii: cvz239. doi: 10.1093/cvr/cvz239. [Epub ahead of print]

PMID:
31504272
20.

Atherosclerosis.

Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokgözoğlu L, Lewis EF.

Nat Rev Dis Primers. 2019 Aug 16;5(1):56. doi: 10.1038/s41572-019-0106-z. Review.

PMID:
31420554

Supplemental Content

Loading ...
Support Center